Alzheimer’s Access: Canada’s Drug Agency (CDA-AMC) issued a final positive recommendation for public reimbursement of LEQEMBI (lecanemab) for eligible people with mild cognitive impairment or mild Alzheimer’s—an important step toward faster treatment access. Drug Pricing Fight: Public Citizen says Trump’s new most-favored-nation drug pricing deals are a “farce,” pointing to missing follow-through and urging Medicare-focused reference pricing instead. Tobacco Regulation: The FDA authorized the JUUL2 system in the U.S. for tobacco-and-menthol pods with 1.6% nicotine, positioning it as a regulated alternative for adult smokers. Vaping Policy Aftermath: The FDA’s decision comes after a major U.S. settlement tied to youth vaping, underscoring how enforcement and product approvals are reshaping the market. First Amendment Clash: A legal analysis warns Meta’s $17B teen safety settlement could amount to “jawboning,” raising concerns about government pressure on speech. Local Pharmacy Access: North Star Health opened three in-house pharmacies in Vermont to address local pharmacy shortages and expand coverage options. Public Health Alert: Michigan confirmed its first 2026 eastern equine encephalitis case in a domestic horse, urging mosquito precautions for families and animals. Care Delivery Model: Michigan school districts are using direct primary care clinics (Plum Health) to offer longer, insurance-free visits and free medications for students and families. Healthcare Operations: Transcat acquired Southeastern Biomedical to expand accredited calibration and regulatory compliance services for hospital networks.